| pubmed-article:6970728 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C0018894 | lld:lifeskim |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C0039195 | lld:lifeskim |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C2004454 | lld:lifeskim |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C1883712 | lld:lifeskim |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:6970728 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
| pubmed-article:6970728 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6970728 | pubmed:dateCreated | 1981-5-13 | lld:pubmed |
| pubmed-article:6970728 | pubmed:abstractText | Spleen cells from mice treated with cyclophosphamide (150 mg/kg) and cultured at suboptimal concentrations do not generate cytotoxic T lymphocytes to allogeneic tumor cells. The reduced response of spleen cells from cyclophosphamide-treated mice is not due to the elimination of cytotoxic T cell precursors because normal responses are obtained by the addition of Lyt-1+2- T helper cells to the culture system. These results indicate that helper cells, required for the development of cytotoxic T cell responses to tumor alloantigens, are eliminated by cyclophosphamide in the absence of evident toxicity to cytotoxic T cell precursors. | lld:pubmed |
| pubmed-article:6970728 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6970728 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6970728 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6970728 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6970728 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6970728 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6970728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6970728 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6970728 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6970728 | pubmed:issn | 0192-0561 | lld:pubmed |
| pubmed-article:6970728 | pubmed:author | pubmed-author:MerluzziV JVJ | lld:pubmed |
| pubmed-article:6970728 | pubmed:author | pubmed-author:ChoiY SYS | lld:pubmed |
| pubmed-article:6970728 | pubmed:author | pubmed-author:FaanesR BRB | lld:pubmed |
| pubmed-article:6970728 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6970728 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:6970728 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6970728 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6970728 | pubmed:pagination | 341-4 | lld:pubmed |
| pubmed-article:6970728 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:meshHeading | pubmed-meshheading:6970728-... | lld:pubmed |
| pubmed-article:6970728 | pubmed:year | 1980 | lld:pubmed |
| pubmed-article:6970728 | pubmed:articleTitle | Recovery of the capacity for cytotoxic T cell generation in cyclophosphamide-treated mice by the addition of LYT-1/2- helper cells. | lld:pubmed |
| pubmed-article:6970728 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6970728 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6970728 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6970728 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6970728 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6970728 | lld:pubmed |
